Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Medtronic
Johnson and Johnson
UBS
Covington
Chubb
Baxter
Healthtrust

Generated: July 19, 2018

DrugPatentWatch Database Preview

Sumatriptan - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for sumatriptan and what is the scope of sumatriptan freedom to operate?

Sumatriptan
is the generic ingredient in nine branded drugs marketed by Glaxosmithkline, Lannett Co Inc, Meridian Medcl, Antares Pharma Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Injectalia, Mylan Asi, Mylan Labs Ltd, Par Pharm, Par Sterile Products, Sandoz Inc, Sun Pharma Global, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Endo Ventures Ltd, Avanir Pharms, Dr Reddys Labs Ltd, Teva Branded Pharm, Apotex Inc, Aurobindo Pharma, Fosun Pharma, Hikma Pharms, Mylan, Orchid Hlthcare, Roxane, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs, and is included in forty-one NDAs. There are thirty-three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for sumatriptan. Four suppliers are listed for this compound. There are seven tentative approvals for this compound.
Medical Subject Heading (MeSH) Categories for sumatriptan
Synonyms for sumatriptan
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide #
1-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide
1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide
1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide
1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide
1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide
103628-46-2
103628-48-4 (succinate)
1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl-
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole -5-methanesulphonamide
3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide
3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide
628S462
8R78F6L9VO
AB0016356
AB00698285_14
AB00698285_15
AB00698285-12
AB00698285-13
AC1L1K6B
AJ-08373
AKOS015894924
Ambap103628-46-2
AN-5271
API0004291
AVP 825
AVP-825
AVP825
BDBM50005835
BIDD:GT0248
BRD-K50938287-001-01-7
BRN 6930870
BSPBio_002304
C07319
C14H21N3O2S
CAS-103628-46-2
CCG-230331
CHEBI:10650
CHEMBL128
D00451
D0Z6UC
DB00669
DR001144
DSSTox_CID_3628
DSSTox_GSID_23628
DSSTox_RID_77118
DTXSID4023628
FT-0631027
GR 43175
GR 43175X
GR-43175
GR43175
GTPL54
HE291385
HMS2231B21
HMS3369A05
HSDB 7742
I06-0076
Imigran (TN)
Imigran Recovery
Imitrex (TN)
Imitrex Oral
Imitrex, Imigran ,Treximet
J-001014
KB-217141
KQKPFRSPSRPDEB-UHFFFAOYSA-N
KS-1116
L000584
LS-83175
MCULE-3991948648
MLS001195659
MLS001304742
MolPort-002-885-863
NCGC00095838-01
NCGC00095838-02
NCGC00095838-03
NCGC00095838-04
NP101
O262
Onzetra Xsail
SBI-0206837.P001
SC-18016
SCHEMBL1482
SMR000596517
SPECTRUM1505372
STL451003
Sumatran
Sumatriptan (JAN/USP/INN)
Sumatriptan [USP:INN:BAN]
Sumatriptanum
Sumatriptanum [INN-Latin]
Sumax
Tox21_111528
Tox21_111528_1
UNII-8R78F6L9VO
Zecuity
Zembrace SymTouch
ZINC14360
Tentative approvals for SUMATRIPTAN
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign UpEQ 25MG BASETABLET;ORAL
➤ Sign Up➤ Sign UpEQ 100MG BASETABLET;ORAL
➤ Sign Up➤ Sign UpEQ 50MG BASETABLET;ORAL

US Patents and Regulatory Information for sumatriptan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Dr Reddys Labs Inc SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 076847-002 Aug 10, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Farmaceutica SUMATRIPTAN SUCCINATE sumatriptan succinate INJECTABLE;SUBCUTANEOUS 200183-001 Sep 16, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078241-003 Aug 10, 2009 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for sumatriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-003 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Medtronic
Fish and Richardson
US Army
Argus Health
Merck
Cerilliant
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.